Table 1. Evaluation of pathogenicity according to FAdV-4 passage number and host age in SPF chickens

Age (d) Group Virus titer (TCID50/dose) Mortality Gross lesions Histological lesion score Virus detection rate Mean bodyweight gain (g) at days post challenge (DPC)
HN HP Liver Heart Liver CT 3 5 10 14
1 LH 6.31 × 107 20/20* 2/20 13/20 1.4 ± 0.37a 1.7 ± 0.86 17/20 12/20
YS4 6.31 × 108 20/20 0/20 17/20 1.5 ± 0.76 1.8 ± 1.01 18/20 13/20
YS9 4.73 × 108 20/20 1/20 13/20 1.5 ± 0.76 1.3 ± 0.85d 19/20 18/20
Control 0/20 0/20 0/20 0.0 ± 0.00 0.0 ± 0.00 0/20 0/20
14 LH 6.31 × 107 0/20 0/20 3/20 0.1 ± 0.31abc 0.0 ± 0.00 0/20 1/20 42.7 14.6 73.6 48.7
YS4 6.31 × 108 4/20 4/20 4/20 1.7 ± 1.27b 0.0 ± 0.00 9/20 13/20 8.3 16.6 49.5 74.0
YS9 4.73 × 108 1/20 1/20 1/20 1.2 ± 0.88c 0.2 ± 0.41d 6/20 7/20 23.3 11.7 60.1 47.7
Control 0/20 0/20 0/20 0.0 ± 0.00 0.0 ± 0.00 0/20 0/20 33.0 19.5 61.3 31.6
Dead chicken number / tested chicken number.
The statistically different values (p<0.05) were observed between groups.
FAdV-4, fowl adenovirus serotype-4; SPF, specific-pathogen-free; LH, liver homogenate; YS4, virus passaged 4 times in yolk sac of SPF chicken embryonated egg; YS9, virus passaged 9 times in yolk sac of SPF chicken embryonated egg; HN, hepatic necrosis; HP, hydrppericardium; CT, cecal tonsil.